Following that, we identified DBT-associated DEGs using bioinformatics analysis and discovered that DBT regulates a number of cancer-related signaling pathways, including the PPAR signaling route, TGF signaling pathway, KEGG-pancreatic cancer, KEGG-prostate cancer, and KEGG-renal cell carcinoma. This evidence concerns the gene DBT and pancreatic neoplasm.